T1	tradename 107 115	SOMAVERT
T3	tradename 178 187	SOMAVERT.
T5	tradename 189 197	SOMAVERT
T7	nanoparticle 199 211	pegvisomant)
T9	routeofadministration 231 243	subcutaneous
T11	fdaapprovaldate 271 275	2003
T13	tradename 489 497	SOMAVERT
T15	indication 569 579	acromegaly
T17	dose 881 886	40 mg
T19	routeofadministration 900 914	subcutaneously
T21	frequency 1043 1048	daily
T23	routeofadministration 1049 1061	subcutaneous
T25	dose 1076 1081	10 mg
T27	indication 1301 1311	acromegaly
T29	dose 1335 1346	10 to 30 mg
T31	frequency 1347 1357	once daily
T33	tradename 1480 1488	SOMAVERT
T35	tradename 2001 2009	SOMAVERT
T37	adversereaction 2149 2158	infection
T39	adversereaction 2160 2164	pain
T41	adversereaction 2166 2172	nausea
T43	adversereaction 2174 2182	diarrhea
T45	adversereaction 2184 2204	abnormal liver tests
T47	adversereaction 2206 2218	flu syndrome
T49	adversereaction 2220 2243	injection site reaction
T51	company 2296 2302	Pfizer
T53	indication 2541 2551	acromegaly
T55	tradename 2731 2739	SOMAVERT
T57	tradename 4052 4060	SOMAVERT
T59	indication 4095 4105	acromegaly
T61	tradename 4412 4420	SOMAVERT
T63	dose 4424 4429	40 mg
T65	routeofadministration 4436 4450	subcutaneously
T67	routeofadministration 4518 4530	subcutaneous
T69	frequency 4603 4613	once daily
T71	routeofadministration 4614 4626	subcutaneous
T73	frequency 4731 4736	daily
T75	routeofadministration 4737 4749	subcutaneous
T77	dose 4764 4769	10 mg
T79	tradename 4773 4782	SOMAVERT.
T81	indication 5013 5024	acromegaly.
T83	tradename 5158 5166	SOMAVERT
T85	dose 5419 5430	10 to 30 mg
T87	routeofadministration 5437 5451	subcutaneously
T89	frequency 5452 5462	once daily
T91	dose 5495 5500	30 mg
T93	routeofadministration 5507 5521	subcutaneously
T95	frequency 5522 5533	once daily.
T97	tradename 5582 5590	SOMAVERT
T99	tradename 5614 5622	SOMAVERT
T101	tradename 5874 5882	SOMAVERT
T103	tradename 5972 5980	SOMAVERT
T105	dose 6163 6168	40 mg
T107	tradename 6267 6275	SOMAVERT
T109	dose 6287 6292	20 mg
T111	nanoparticle 6296 6307	pegvisomant
T113	dose 6410 6415	40 mg
T115	tradename 6499 6507	SOMAVERT
T117	tradename 6728 6736	SOMAVERT
T119	dose 6748 6753	20 mg
T121	nanoparticle 6757 6768	pegvisomant
T123	tradename 7032 7041	SOMAVERT.
T125	nanoparticle 7183 7194	pegvisomant
T127	tradename 7333 7341	SOMAVERT
T129	tradename 7471 7479	SOMAVERT
T131	dose 7690 7695	20 mg
T133	nanoparticle 7699 7710	pegvisomant
T135	tradename 7770 7778	SOMAVERT
T137	tradename 7895 7903	SOMAVERT
T139	routeofadministration 7924 7938	subcutaneously
T141	tradename 8085 8093	Somavert
T143	dose 8102 8107	20mg.
T145	tradename 8155 8163	SOMAVERT
T147	routeofadministration 8184 8198	subcutaneously
T149	frequency 8452 8457	daily
T151	dose 8465 8477	10 to 30 mg)
T153	tradename 8607 8615	SOMAVERT
T155	dose 8627 8629	10
T157	dose 8631 8642	15 or 20 mg
T159	nanoparticle 8646 8657	pegvisomant
T161	tradename 8926 8935	SOMAVERT.
T163	nanoparticle 9074 9085	pegvisomant
T165	tradename 9224 9232	SOMAVERT
T167	tradename 9364 9372	SOMAVERT
T169	dose 9583 9585	10
T171	dose 9587 9598	15 or 20 mg
T173	nanoparticle 9602 9613	pegvisomant
T175	tradename 9672 9680	SOMAVERT
T177	tradename 9790 9798	SOMAVERT
T179	routeofadministration 9808 9822	subcutaneously
T181	frequency 9920 9925	daily
T183	dose 9936 9947	25 or 30 mg
T185	tradename 10005 10013	Somavert
T187	dose 10046 10058	25 or 30 mg.
T189	frequency 10077 10082	daily
T191	dose 10093 10104	25 or 30 mg
T193	tradename 10138 10146	SOMAVERT
T195	routeofadministration 10156 10170	subcutaneously
T197	tradename 10795 10804	SOMAVERT.
T199	tradename 11187 11196	SOMAVERT.
T201	tradename 11267 11275	SOMAVERT
T203	tradename 11653 11661	SOMAVERT
T205	tradename 11783 11791	Somavert
T207	tradename 11850 11858	SOMAVERT
T209	tradename 11919 11927	SOMAVERT
T211	tradename 11997 12006	SOMAVERT.
T213	tradename 12216 12224	SOMAVERT
T215	tradename 12391 12399	SOMAVERT
T217	tradename 12693 12702	SOMAVERT.
T219	tradename 12899 12907	SOMAVERT
T221	tradename 13041 13049	SOMAVERT
T223	tradename 13271 13280	SOMAVERT.
T225	tradename 13666 13674	SOMAVERT
T227	tradename 13959 13967	SOMAVERT
T229	tradename 14353 14361	SOMAVERT
T231	tradename 14556 14564	SOMAVERT
T233	indication 14666 14676	acromegaly
T235	adversereaction 14763 14778	Lipohypertrophy
T237	adversereaction 14805 14820	lipohypertrophy
T239	tradename 14846 14855	SOMAVERT.
T241	adversereaction 14939 14969	injection site lipohypertrophy
T243	dose 15002 15007	10 mg
T245	frequency 15007 15012	/day.
T247	dose 15157 15162	10 mg
T249	frequency 15162 15166	/day
T251	adversereaction 15182 15198	lipohypertrophy.
T253	adversereaction 15352 15367	lipohypertrophy
T255	adversereaction 15416 15441	Systemic Hypersensitivity
T257	adversereaction 15460 15495	systemic hypersensitivity reactions
T259	tradename 15565 15573	Somavert
T261	adversereaction 15974 15989	Lipohypertrophy
T263	adversereaction 16028 16053	Systemic hypersensitivity
T265	tradename 16222 16230	SOMAVERT
T267	tradename 16300 16308	SOMAVERT
T269	tradename 16954 16962	SOMAVERT
T271	tradename 17507 17515	SOMAVERT
T273	indication 17533 17543	acromegaly
T275	tradename 17599 17607	SOMAVERT
T277	frequency 17608 17618	once daily
T279	tradename 17688 17697	Somavert)
T281	indication 17770 17780	acromegaly
T283	adversereaction 17895 17918	transaminase elevations
T285	adversereaction 17937 17975	lipohypertrophy at the injection sites
T287	adversereaction 17998 18022	substantial weight gain.
T289	tradename 18184 18192	SOMAVERT
T291	indication 18366 18377	Acromegaly*
T293	tradename 18394 18402	SOMAVERT
T295	dose 18403 18408	10 mg
T297	frequency 18408 18412	/day
T299	dose 18419 18424	15 mg
T301	frequency 18424 18428	/day
T303	dose 18435 18440	20 mg
T305	frequency 18440 18444	/day
T307	adversereaction 18451 18462	Infection 2
T309	adversereaction 18480 18484	Pain
T311	adversereaction 18514 18520	Nausea
T313	adversereaction 18545 18553	Diarrhea
T315	adversereaction 18578 18607	Abnormal liver function tests
T317	adversereaction 18637 18649	Flu syndrome
T319	adversereaction 18674 18697	Injection site reaction
T321	adversereaction 18722 18731	Dizziness
T323	adversereaction 18760 18777	Accidental injury
T325	adversereaction 18801 18810	Back pain
T327	adversereaction 18834 18843	Sinusitis
T329	adversereaction 18867 18877	Chest pain
T331	adversereaction 18896 18912	Peripheral edema
T333	adversereaction 18931 18943	Hypertension
T335	adversereaction 18957 18968	Paresthesia
T337	tradename 19115 19123	SOMAVERT
T339	tradename 19224 19232	SOMAVERT
T341	dose 19233 19238	10 mg
T343	adversereaction 19256 19269	cold symptoms
T345	adversereaction 19275 19302	upper respiratory infection
T347	adversereaction 19308 19315	blister
T349	adversereaction 19325 19338	ear infection
T351	adversereaction 19395 19408	cold symptoms
T353	adversereaction 19417 19432	chest infection
T355	tradename 19520 19536	SOMAVERT-treated
T357	tradename 19688 19696	SOMAVERT
T359	tradename 19859 19868	SOMAVERT.
T361	tradename 19983 19992	SOMAVERT.
T363	tradename 20379 20387	SOMAVERT
T365	tradename 20571 20580	SOMAVERT.
T367	adversereaction 20785 20820	Systemic hypersensitivity reactions
T369	adversereaction 20831 20853	anaphylactic reactions
T371	adversereaction 20855 20867	laryngospasm
T373	adversereaction 20869 20879	angioedema
T375	adversereaction 20909 20913	rash
T377	adversereaction 20915 20923	erythema
T379	adversereaction 20925 20933	pruritus
T381	adversereaction 20935 20945	urticaria)
T383	indication 21156 21166	Acromegaly
T385	tradename 21180 21188	SOMAVERT
T387	indication 21295 21305	acromegaly
T389	tradename 21319 21327	SOMAVERT
T391	tradename 21818 21826	SOMAVERT
T393	tradename 21858 21866	SOMAVERT
T395	indication 21883 21894	acromegaly.
T397	adversereaction 22054 22069	Lipohypertrophy
T399	tradename 22873 22881	SOMAVERT
T401	indication 22897 22907	acromegaly
T403	tradename 23172 23180	SOMAVERT
T405	nanoparticle 23548 23559	pegvisomant
T407	routeofadministration 23563 23575	subcutaneous
T409	dose 23585 23586	1
T411	dose 23588 23589	3
T413	dose 23591 23603	and 10 mg/kg
T415	frequency 23603 23608	/day.
T417	nanoparticle 23670 23681	pegvisomant
T419	dose 23722 23730	10mg/kg/
T421	frequency 23730 23733	day
T423	tradename 23983 23991	SOMAVERT
T425	nanoparticle 24095 24106	pegvisomant
T427	tradename 24209 24217	SOMAVERT
T429	tradename 24307 24315	SOMAVERT
T431	tradename 24406 24414	SOMAVERT
T433	tradename 24829 24837	SOMAVERT
T435	tradename 25016 25024	SOMAVERT
T437	dose 25092 25097	80 mg
T439	frequency 25097 25101	/day
T441	tradename 25361 25369	SOMAVERT
T443	tradename 25490 25498	SOMAVERT
T445	nanoparticle 25508 25519	pegvisomant
T447	nanoparticle 25632 25643	Pegvisomant
T449	activeingredient 25649 25717	protein of recombinant DNA origin containing 191 amino acid residues
T451	surfacecoating 25735 25760	polyethylene glycol (PEG)
T453	surfacecoating 25813 25817	PEG/
T455	nanoparticle 25876 25887	pegvisomant
T457	molecularweight 25891 25893	21
T459	molecularweight 25894 25906	998 Daltons.
T461	surfacecoating 25936 25939	PEG
T463	nanoparticle 25951 25962	pegvisomant
T465	molecularweight 25980 25993	5000 Daltons.
T467	nanoparticle 26032 26043	pegvisomant
T469	molecularweight 26067 26069	42
T471	molecularweight 26070 26073	000
T473	molecularweight 26075 26077	47
T475	molecularweight 26078 26081	000
T477	molecularweight 26083 26089	and 52
T479	molecularweight 26090 26102	000 Daltons.
T481	nanoparticle 26155 26166	pegvisomant
T483	surfacecoating 26176 26188	PEG polymers
T485	nanoparticle 26251 26262	Pegvisomant
T487	tradename 26523 26531	Somavert
T489	surfacecoating 26742 26745	PEG
T491	nanoparticle 26891 26902	pegvisomant
T493	nanoparticle 26935 26946	Pegvisomant
T495	tradename 27101 27109	SOMAVERT
T497	routeofadministration 27188 27200	subcutaneous
T499	tradename 27275 27283	SOMAVERT
T501	nanoparticle 27357 27368	pegvisomant
T503	inactiveingredient 27470 27477	glycine
T505	inactiveingredient 27490 27498	mannitol
T507	inactiveingredient 27511 27545	sodium phosphate dibasic anhydrous
T509	inactiveingredient 27562 27601	sodium phosphate monobasic monohydrate.
T511	tradename 27604 27612	SOMAVERT
T513	nanoparticle 27964 27975	Pegvisomant
T515	nanoparticle 28408 28419	Pegvisomant
T517	nanoparticle 28545 28556	Pegvisomant
T519	routeofadministration 28722 28734	subcutaneous
T521	nanoparticle 28762 28773	pegvisomant
T523	tmax 28822 28836	33 to 77 hours
T525	dose 28895 28900	20-mg
T527	routeofadministration 28901 28913	subcutaneous
T529	dose 28942 28947	10-mg
T531	routeofadministration 28948 28959	intravenous
T533	nanoparticle 29025 29036	pegvisomant
T535	volumeofdistribution 29040 29043	7 L
T537	nanoparticle 29092 29103	pegvisomant
T539	routeofadministration 29166 29178	subcutaneous
T541	nanoparticle 29221 29232	pegvisomant
T543	nanoparticle 29301 29312	pegvisomant
T545	frequency 29359 29364	daily
T547	dose 29374 29376	10
T549	dose 29378 29380	15
T551	dose 29382 29391	and 20 mg
T553	cmax 29397 29407	6600 1330
T555	cmax 29409 29411	16
T557	cmax 29412 29421	000 2200
T559	cmax 29423 29429	and 27
T561	cmax 29430 29444	000 3100 ng/mL
T563	nanoparticle 29494 29505	pegvisomant
T565	surfacecoating 29541 29560	polyethylene glycol
T567	nanoparticle 29623 29634	pegvisomant
T569	nanoparticle 29747 29758	pegvisomant
T571	clearance 29814 29827	36 to 28 mL/h
T573	routeofadministration 29832 29844	subcutaneous
T575	dose 29864 29875	10 to 20 mg
T577	frequency 29875 29879	/day
T579	nanoparticle 29909 29920	pegvisomant
T581	nanoparticle 29962 29973	Pegvisomant
T583	plasmahalflife 30038 30052	74 - 172 hours
T585	nanoparticle 30198 30209	pegvisomant
T587	nanoparticle 30336 30347	pegvisomant
T589	nanoparticle 30760 30771	pegvisomant
T591	nanoparticle 30839 30850	pegvisomant
T593	nanoparticle 31006 31017	Pegvisomant
T595	routeofadministration 31035 31049	subcutaneously
T597	frequency 31058 31063	daily
T599	dose 31088 31089	2
T601	dose 31091 31105	8 and 20 mg/kg
T603	dose 31140 31145	20 mg
T605	nanoparticle 31205 31216	pegvisomant
T607	dose 31220 31234	8 and 20 mg/kg
T609	routeofadministration 31524 31536	subcutaneous
T611	nanoparticle 31563 31574	Pegvisomant
T613	nanoparticle 31720 31731	Pegvisomant
T615	routeofadministration 31822 31834	subcutaneous
T617	dose 31847 31856	10 mg/kg/
T619	frequency 31856 31859	day
T621	indication 32015 32025	acromegaly
T623	tradename 32120 32129	SOMAVERT.
T625	indication 32189 32199	acromegaly
T627	dose 32927 32932	10 mg
T629	frequency 32932 32936	/day
T631	dose 32945 32950	15 mg
T633	frequency 32950 32954	/day
T635	dose 32967 32972	20 mg
T637	frequency 32972 32976	/day
T639	tradename 32987 32995	SOMAVERT
T641	routeofadministration 32996 33015	subcutaneouslyIGF-I
T643	tradename 33154 33162	SOMAVERT
T645	tradename 33400 33408	SOMAVERT
T647	dose 33409 33414	10 mg
T649	frequency 33414 33418	/day
T651	dose 33425 33430	15 mg
T653	frequency 33430 33434	/day
T655	dose 33441 33446	20 mg
T657	frequency 33446 33450	/day
T659	tradename 33620 33628	SOMAVERT
T661	tradename 33950 33958	SOMAVERT
T663	tradename 34218 34226	SOMAVERT
T665	indication 34347 34358	acromegaly.
T667	indication 34407 34417	acromegaly
T669	indication 34633 34643	acromegaly
T671	indication 34980 34990	Acromegaly
T673	tradename 35001 35009	SOMAVERT
T675	dose 35016 35022	10 mg/
T677	frequency 35022 35025	day
T679	dose 35031 35037	15 mg/
T681	frequency 35037 35040	day
T683	dose 35050 35056	20 mg/
T685	frequency 35056 35059	day
T687	indication 35161 35171	acromegaly
T689	nanoparticle 35615 35626	pegvisomant
T691	tradename 35678 35687	SOMAVERT.
T693	tradename 35773 35781	SOMAVERT
T695	dose 35782 35788	20 mg/
T697	frequency 35788 35792	day.
T699	indication 35936 35946	acromegaly
T701	tradename 35976 35984	SOMAVERT
T703	tradename 36181 36189	SOMAVERT
T705	adversereaction 36569 36578	headaches
T707	adversereaction 36580 36609	elevated liver function tests
T709	adversereaction 36611 36628	pancreatic cancer
T711	adversereaction 36634 36646	weight gain)
T713	tradename 36823 36831	SOMAVERT
T715	nanoparticle 36833 36845	pegvisomant)
T717	tradename 36914 36922	SOMAVERT
T719	nanoparticle 36924 36936	pegvisomant)
T721	tradename 37200 37208	SOMAVERT
T723	tradename 37528 37537	SOMAVERT:
T725	tradename 37550 37558	SOMAVERT
T727	tradename 37583 37591	SOMAVERT
T729	tradename 37712 37720	SOMAVERT
T731	tradename 37742 37750	SOMAVERT
T733	tradename 37803 37811	SOMAVERT
T735	tradename 37980 37988	SOMAVERT
T737	tradename 38402 38411	SOMAVERT.
T739	indication 38568 38578	acromegaly
T741	tradename 38938 38947	SOMAVERT.
T743	tradename 38992 39000	SOMAVERT
T745	tradename 39072 39080	SOMAVERT
T747	tradename 39612 39620	SOMAVERT
T749	tradename 39740 39748	SOMAVERT
T751	nanoparticle 39763 39774	pegvisomant
T753	tradename 39798 39807	SOMAVERT?
T755	tradename 39809 39817	SOMAVERT
T757	indication 39900 39911	acromegaly)
T759	tradename 39914 39922	SOMAVERT
T761	tradename 40055 40063	SOMAVERT
T763	tradename 40155 40164	SOMAVERT?
T765	tradename 40181 40189	SOMAVERT
T767	nanoparticle 40246 40257	pegvisomant
T769	tradename 40287 40296	SOMAVERT.
T771	tradename 40310 40318	SOMAVERT
T773	nanoparticle 40342 40353	pegvisomant
T775	tradename 40383 40392	SOMAVERT.
T777	tradename 40460 40469	SOMAVERT.
T779	tradename 40578 40586	SOMAVERT
T781	tradename 40681 40690	SOMAVERT.
T783	tradename 40753 40761	SOMAVERT
T785	tradename 40858 40866	SOMAVERT
T787	tradename 41039 41047	SOMAVERT
T789	tradename 41124 41132	SOMAVERT
T791	tradename 41327 41335	SOMAVERT
T793	tradename 41627 41636	SOMAVERT?
T795	tradename 41750 41759	SOMAVERT.
T797	tradename 41911 41920	SOMAVERT.
T799	tradename 41978 41987	SOMAVERT.
T801	tradename 41989 41997	SOMAVERT
T803	frequency 42007 42022	1 time each day
T805	routeofadministration 42056 42069	subcutaneous)
T807	tradename 42253 42261	SOMAVERT
T809	tradename 42377 42386	SOMAVERT.
T811	tradename 42409 42417	SOMAVERT
T813	tradename 42486 42494	SOMAVERT
T815	tradename 42688 42697	SOMAVERT?
T817	tradename 42699 42707	SOMAVERT
T819	tradename 42870 42879	SOMAVERT.
T821	tradename 42914 42922	SOMAVERT
T823	tradename 43637 43645	SOMAVERT
T825	tradename 43895 43904	SOMAVERT.
T827	tradename 44206 44215	SOMAVERT?
T829	tradename 44236 44244	SOMAVERT
T831	tradename 44275 44283	SOMAVERT
T833	tradename 44349 44358	SOMAVERT.
T835	tradename 44378 44386	SOMAVERT
T837	tradename 44422 44430	SOMAVERT
T839	tradename 44494 44502	SOMAVERT
T841	tradename 44591 44599	SOMAVERT
T843	tradename 44665 44673	SOMAVERT
T845	tradename 44700 44708	SOMAVERT
T847	tradename 44721 44729	SOMAVERT
T849	tradename 44835 44844	SOMAVERT.
T851	tradename 44964 44972	SOMAVERT
T853	tradename 45035 45043	SOMAVERT
T855	tradename 45206 45215	SOMAVERT.
T857	tradename 45365 45373	SOMAVERT
T859	tradename 45516 45525	SOMAVERT?
T861	nanoparticle 45546 45557	pegvisomant
T863	surfacecoating 45569 45588	polyethylene glycol
T865	inactiveingredient 45612 45619	glycine
T867	inactiveingredient 45621 45629	mannitol
T869	inactiveingredient 45631 45665	sodium phosphate dibasic anhydrous
T871	inactiveingredient 45671 45709	sodium phosphate monobasic monohydrate
T873	tradename 45733 45741	SOMAVERT
T875	nanoparticle 45757 45768	pegvisomant
T877	tradename 45792 45800	SOMAVERT
T879	routeofadministration 45833 45846	subcutaneous)
T881	tradename 45867 45875	SOMAVERT
T883	tradename 46026 46035	SOMAVERT.
T885	tradename 46064 46072	SOMAVERT
T887	tradename 46108 46116	SOMAVERT
T889	tradename 46270 46278	SOMAVERT
T891	tradename 46342 46350	SOMAVERT
T893	tradename 46939 46947	SOMAVERT
T895	tradename 46962 46970	SOMAVERT
T897	tradename 47018 47026	SOMAVERT
T899	tradename 47099 47107	SOMAVERT
T901	tradename 47217 47225	SOMAVERT
T903	tradename 47255 47263	SOMAVERT
T905	tradename 47334 47342	SOMAVERT
T907	tradename 47411 47419	SOMAVERT
T909	tradename 47440 47448	SOMAVERT
T911	tradename 49540 49549	SOMAVERT.
T913	tradename 49668 49676	SOMAVERT
T915	tradename 50186 50194	SOMAVERT
T917	tradename 50749 50757	SOMAVERT
T919	tradename 50919 50928	SOMAVERT.
T921	tradename 51000 51008	SOMAVERT
T923	tradename 51079 51087	SOMAVERT
T925	tradename 52418 52426	SOMAVERT
T927	tradename 52688 52696	SOMAVERT
T929	tradename 52812 52820	SOMAVERT
T931	tradename 53111 53119	SOMAVERT
T933	tradename 53146 53154	SOMAVERT
T935	routeofadministration 53183 53196	subcutaneous)
T937	tradename 53567 53576	SOMAVERT.
T939	tradename 53726 53734	SOMAVERT
T941	tradename 53800 53808	SOMAVERT
